Literature DB >> 21816800

Impact of insulin-sensitizing agents on risk for liver cancer and liver-related death in diabetic patients with compensated hepatitis C cirrhosis.

Violeta B Popov, Joseph K Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21816800     DOI： 10.1210/jc.2011-1875

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.

Authors:  Mary-Anne Doyle; Joel Singer; Terry Lee; Miriam Muir; Curtis Cooper
Journal:  Trials       Date:  2016-07-20       Impact factor: 2.279

2.  Neocornuside A-D, Four Novel Iridoid Glycosides from Fruits of Cornus officinalis and Their Antidiabetic Activity.

Authors:  Meng Yang; Zhiyou Hao; Xiaolan Wang; Shiqi Zhou; Denghui Zhu; Ying Yang; Junjun Wei; Meng Li; Xiaoke Zheng; Weisheng Feng
Journal:  Molecules       Date:  2022-07-24       Impact factor: 4.927

3.  Efficacy of adding metformin to pegylated interferon and ribavirin in treatment naïve patients with chronic hepatitis C: a randomized double-blind controlled trial.

Authors:  Amir Houshang Sharifi; Mastaneh Mohammadi; Elham Fakharzadeh; Hediyeh Zamini; Hanieh Zaer-Rezaee; Hossain Jabbari; Shahin Merat
Journal:  Middle East J Dig Dis       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.